Physician profile
Caitlin Yoder
NPI 1003390287
$2,791.64
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $257 · 2023: $468 · 2024: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,229 · Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,228.99 |
| Food and Beverage | $1,083.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,817.31 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $276.18 | 2023-2024 | Gemtesa |
| Abbvie INC. | $197.88 | 2021-2023 | |
| Medtronic, INC. | $102.46 | 2022 | |
| Astellas Pharma US INC | $100.03 | 2023-2024 | Myrbetriq, Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.63 | 2021 | |
| Coloplast Corp | $37.10 | 2023-2024 | Restorelle |
| Davol INC. | $36.20 | 2023 | Arista Ah Flexitip |
| Urovant Sciences INC | $31.14 | 2022 | |
| Glaxosmithkline, LLC. | $27.62 | 2021-2022 | |
| Amgen INC. | $27.32 | 2021 | |
| Boston Scientific Corporation | $25.11 | 2023 | |
| Nestle Healthcare Nutrition INC. | $20.32 | 2021 | |
| Olympus America INC. | $20.09 | 2023 | Olympus |
| Takeda Pharmaceuticals U.S.A., INC. | $14.75 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.